Canadian application, no grantCanada
Method for treating human papilloma virus
CA 2746308 A1 · Owner: Zymogenetics, Inc. · Inventors: Chandrasekher, Yasmin A.; Mckernan, Patricia A.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Use of Interleukin-20 for treating cells infected with human papilloma virus. IL-20 can be administered alone or in conjunction with radiation or chemotherapeutic agents, or surgical excision of the involved cells or lesions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 17, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 17, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 17, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 17, 2002
GrantedNo grant recorded
Term endedDecember 17, 2022
Patent numberCA 2746308 A1
Classification (IPC)A61K38/20 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.